Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Non Operating Income (2016)

Historic Other Non Operating Income for China Pharma Holdings (CPHI) over the last 6 years, with Q4 2016 value amounting to -$3324.0.

  • China Pharma Holdings' Other Non Operating Income rose 7806.23% to -$3324.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $327871.0, marking a year-over-year decrease of 8001.47%. This contributed to the annual value of $343023.0 for FY2016, which is 7909.07% down from last year.
  • Latest data reveals that China Pharma Holdings reported Other Non Operating Income of -$3324.0 as of Q4 2016, which was up 7806.23% from -$2325.0 recorded in Q3 2016.
  • China Pharma Holdings' 5-year Other Non Operating Income high stood at $1.7 million for Q3 2015, and its period low was -$15152.0 during Q4 2015.
  • In the last 3 years, China Pharma Holdings' Other Non Operating Income had a median value of $27.0 in 2014 and averaged $292666.7.
  • Data for China Pharma Holdings' Other Non Operating Income shows a peak YoY increase of 244383.89% (in 2015) and a maximum YoY decrease of 5621851.85% (in 2015) over the last 5 years.
  • Quarter analysis of 3 years shows China Pharma Holdings' Other Non Operating Income stood at $27.0 in 2014, then tumbled by 56218.52% to -$15152.0 in 2015, then surged by 78.06% to -$3324.0 in 2016.
  • Its Other Non Operating Income stands at -$3324.0 for Q4 2016, versus -$2325.0 for Q3 2016 and $348672.0 for Q2 2016.